BioHarvest Sciences Gross Profit 2020-2024 | BHST
BioHarvest Sciences gross profit from 2020 to 2024. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
BioHarvest Sciences Annual Gross Profit (Millions of US $) |
2023 |
$6 |
2022 |
$1 |
2021 |
$1 |
2020 |
$0 |
2019 |
$0 |
2019 |
$ |
2018 |
$ |
BioHarvest Sciences Quarterly Gross Profit (Millions of US $) |
2024-06-30 |
$3 |
2024-03-31 |
$3 |
2023-12-31 |
$2 |
2023-09-30 |
$1 |
2023-06-30 |
$1 |
2023-03-31 |
$1 |
2022-12-31 |
$1 |
2022-09-30 |
$0 |
2022-06-30 |
$0 |
2022-03-31 |
$0 |
2021-12-31 |
$0 |
2021-09-30 |
$0 |
2021-06-30 |
$0 |
2021-03-31 |
$0 |
2020-12-31 |
$0 |
2020-09-30 |
$0 |
2020-06-30 |
$0 |
2020-03-31 |
$0 |
2019-12-31 |
|
2019-09-30 |
$0 |
2019-06-30 |
$0 |
2019-03-31 |
|
Sector |
Industry |
Market Cap |
Revenue |
Medical |
MED-BIOMED/GENE |
$0.098B |
$0.013B |
BioHarvest Sciences Inc. is a biotech firm. It focused on leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions, within business verticals nutraceutical health and wellness products such as dietary supplements and development of plant cell-based Active Pharmaceutical Ingredients which focus on specific medical indications. BioHarvest Sciences Inc. is based in Vancouver, Canada.
|